The total return over the past 12 months is -11.04% vs. +16.94% for the S&P 500. So far it's up 0.00% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (11.04%) | +26.42% | (13.77%) | N/A | N/A | N/A |
| Total Return CAGR | (11.04%) | +26.42% | (13.77%) | N/A | N/A | N/A |
| Revenue CAGR | +0.64% | +10.42% | +46.05% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Strata Critical Medical, Inc. (SRTA)
| Year | Start price | End price | SRTA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $4.81 | $4.81 | 0.00% | +14.51% | (14.51%) |
| 2025 | $4.25 | $4.81 | +13.18% | +17.72% | (4.54%) |
| 2024 | $3.53 | $4.25 | +20.40% | +24.89% | (4.49%) |
| 2023 | $3.58 | $3.53 | (1.40%) | +26.19% | (27.59%) |
| 2022 | $8.83 | $3.58 | (59.46%) | (18.17%) | (41.29%) |
| 2021 | $11.08 | $8.83 | (20.31%) | +28.74% | (49.05%) |
| 2020 | $9.83 | $11.08 | +12.72% | +18.37% | (5.65%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
